Skip to content
Contact us
Contact us
Ask LynxScribe
LynxScribe
Start new conversation

Navigate The AI Revolution With Confidence

We blend industry knowledge and technology expertise to enable ethical AI utilization
lynx-analytics-infographics-943x566

Transform Pharma with Generative AI

At Lynx Analytics, we accelerate the adoption of generative AI for pharma and life sciences. Our goal is to help organizations seamlessly integrate AI into existing systems, empowering them to drive meaningful business outcomes. With deep expertise in life sciences and artificial intelligence, we enable pharma companies to harness the full potential of their data, making smarter, faster decisions that enhance customer engagement and operational efficiency.

Our Edge Key-1659x701

Our Edge

We simplify complex problems with cutting-edge technology. By combining Graph AI with Retrieval Augmented Generation (RAG), we pioneer innovative solutions like Graph RAG. This unique approach integrates Graph AI and Large Language Models (LLMs), empowering our generative AI solutions to comprehend context, infer relationships, and deliver responses that are highly relevant and contextually accurate. Additionally, our patented methodologies create robust simulation and optimization environments that drive impactful decision-making.

 

Our Edge Key-1659x701

Our Clients

genentech
AstraZeneca-Logo-1.wine
amgen
novo-nordisk
Organon-logo.svg
Cytovia_Logo_Logo
HMBD_Header-Logo-536x162-1
levis
sephora
1200px-HKT_Logo.svg
Frame-5-1
insead-logo
zespri
DBS-Bank-logo
ING_Group_N.V._Logo.svg
UBS-logo

Our Expertise

Lynx Analytics develops AI solutions that empower MSL, Marketing, and Sales teams:

KOL Management
KOL Management

Automatically create rankings based on internal and external data and bring into focus those physicians, researchers, and academics that can
have the most influence for any given drug or therapy area.

Auto-Segmentation
Gen AI Segmentation with Internet-Scale Data/External Data 

Adapt to the latest data for precise customer segmentation.

 

Marketing Mix Optimization
Marketing Mix Optimization

AI-driven recommendations on marketing spend allocation per channel.

Next Best Action
Rep Activity Guidance & Next Best Action

Direct reps on next steps to optimize engagement and boost sales.

Prescription Barrier
Prescription Barrier Identification & Content Recommendation

Flag obstacles to prescriptions and suggest personalized content to overcome these barriers.

360-Degree Customer View
360-Degree Customer View

Unify data from multiple sources for a complete, real-time view of healthcare providers (HCPs).

What-If Scenarios
What-If Scenarios

Use simulations to explore campaign ROI predictions on a per-channel basis.

clinical-trial-research
Improve Clinical Trials and R&D

Optimize clinical trial based on endpoints & participants. Improve bench research & refine criteria while ensuring safety.

Our Technology Partners

nvidia-inception-premier-member-program-badge-rgb-for-screen
OpenAI_Logo.svg (1)
Google Cloud
Azure
Amazon_Web_Services-Logo.wine
databricks-removebg-preview

Problem Solving Across Industries

Life Sciences

Learn how you can leverage big data and AI to improve your medical and commercial results with our solutions for the life sciences and healthcare vertical.

Telecoms

Predict customer data, manage churn, plan and optimize your network and drive engagement to your app with our solutions.

Retail

Leverage on our retail solutions for assortment optimization, demand forecasting, gaining deep customer insights and more.

Banking

Increase customer acquisition and customer retention across online and offline channels with our banking solutions.

Highlights

Image_20250522_181333_978-1

$60M Reallocated. $100M Revenue Uplift.

Discover how Lynx Analytics' AI solution enabled a pharma giant to reallocate $60M in spend and unlock $100M in revenue with data-driven insights. 
 
Read Now
IMG_7531

GITEX Asia 2025 

An engaging panel discussion on "The Art of Tightrope Walking: Balancing TCO in AI Research and Deployment" with Nebius, NVIDIA, and Antler. We explored how organizations can drive AI innovation while maintaining a strong focus on cost-efficiency.

1742475642761

LynxKite 2000:MM unveiled at GTC

At GTC 2025, our CEO Gyorgy Lajtai and Chief Software Architect Daniel Darabos took the stage to showcase how LynxKite 2000:MM is revolutionizing industries like pharmaceuticals by enabling insights in drug discovery, molecular interactions, and personalized medicine. With NVIDIA BioNeMo, RDKit, and Graph Neural Networks, we’re empowering researchers to accelerate hypothesis generation and enhance decision-making in biomedical research.

14703a36-8f54-444e-a60f-d8858903fb05

Meeting of the minds at ATxInspire

Jensen Huang, CEO of NVIDIA, was discussing with Gyorgy Lajtai, CEO of Lynx Analytics, about the barrier that exists between “Fast Thinking” and Reasoning (aka “Slow Thinking”). A barrier Lynx Analytics is directly addressing and that Jensen considers to be the next breakthrough in AI.

Knowledge Center

Explore our vast collection of resources.

Explore

Join the Lynx Analytics Team

Be part of something extraordinary! Collaborate with some of the world’s largest companies as we continually expand our knowledge base and global presence. We're on the lookout for ambitious, innovative, empathetic, and relentless team players. Explore exciting career opportunities with us as we scale our operations and redefine the future of AI together.
Join Us